These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1956560

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. An unusual case of primary systemic amyloidosis.
    Ambrosone L, Mansi L, Salvatore T, Marino F, Orabona P, Rambaldi A, Rambaldi PF, Rambaldi M.
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):53-7. PubMed ID: 9552758
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Colchicine therapy of the renal amyloidosis of ulcerative colitis.
    Meyers S, Janowitz HD, Gumaste VV, Abramson RG, Berman LJ, Venkataseshan VS, Dickman SH.
    Gastroenterology; 1988 Jun; 94(6):1503-7. PubMed ID: 3360271
    [Abstract] [Full Text] [Related]

  • 31. Colchicine for secondary nephropathic amyloidosis in cystic fibrosis.
    Kuwertz-Bröking E, Koch HG, Schulze Everding A, Bulla M, Dworinczak B, Helmchen U, Harms E.
    Lancet; 1995 May 06; 345(8958):1178-9. PubMed ID: 7723568
    [No Abstract] [Full Text] [Related]

  • 32. [Systemic Al-amyloidosis. Clinical course and limits of melphalan therapy].
    Hetzel GR, Heering P, Grabensee B.
    Med Klin (Munich); 1999 Oct 15; 94(10):549-55. PubMed ID: 10554513
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Colchicine-sensitive nephrotic syndrome due to AA amyloidosis.
    Hausmann MJ, Maor E, Kachko L.
    Amyloid; 2011 Sep 15; 18(3):169-71. PubMed ID: 21770831
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
    Gertz MA, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Kyle RA.
    J Clin Oncol; 1999 Jan 15; 17(1):262-7. PubMed ID: 10458241
    [Abstract] [Full Text] [Related]

  • 40. Colchicine induced remission in amyloid nephrotic syndrome.
    Oren R, Pizov G, Naparstek Y, Rubinow A.
    Clin Rheumatol; 1993 Dec 15; 12(4):532-4. PubMed ID: 8124919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.